Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study.
J Hepatocell Carcinoma
; 8: 837-850, 2021.
Article
in En
| MEDLINE
| ID: mdl-34350139
Full text:
1
Database:
MEDLINE
Traditional Medicines:
Medicinas_tradicionales_de_asia
/
Medicina_china
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
J Hepatocell Carcinoma
Year:
2021
Type:
Article